Trial Profile
Clinical Trials Insight: 700049504
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2009
Price :
$35
*
At a glance
- Drugs VX 702 (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Vertex Pharmaceuticals
- 03 Oct 2009 New trial record.